Home
Conditions
Hemic and Lymphatic Diseases

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,112 public trials 3,999 recruiting studies

Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Study of Luspatercept in People With Anemia

NCT07725497

Conditions: Anemia, Chronic Disease, Chronic Kidney Disease, +13 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering at Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

NCT06445517

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

Shanghai Jiao Tong University School of Medicine-Ruijin Hospital Shanghai, Shanghai Municipality, China

Tianjin Medical University Cancer Institute&Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.

NCT07278661

Conditions: Blood Platelet Disorders, Chirurgical Intervention, Cytopenia, +4 more
Locations: CHU d'Angers Angers, France

CHU de Bordeaux Bordeaux, France

CHU de Brest Brest, France

CHU de Dijon Dijon, France

View Trial Details

Recruiting

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

NCT07579065

Conditions: Behavior, Behavioral Symptoms, Cancer Survivorship, +10 more
Locations: Research and EBP Unit, Azienda USL-IRCCS di Reggio Emilia Reggio Emilia, Italy

View Trial Details

Recruiting

A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag

NCT07587723

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Novartis Basel, Switzerland

View Trial Details

Recruiting

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

NCT06912763

Conditions: Fibrosis, Fibrosis Syndrome, Head &Amp; Neck Cancer, +8 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Phase II Study of QLC2519 in Pediatric Solid Tumor Participants

NCT07724756

Conditions: Agranulocytosis, Cytopenia, Febrile Neutropenia, +7 more
Locations: Beijing Children's Hospital Beijing, China

View Trial Details

Recruiting

Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

NCT06580106

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

NCT07725263

Conditions: Agranulocytosis, Anemia, Anemia, Hemolytic, +18 more
Locations: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine Haikou, Hainan, China

View Trial Details

Recruiting

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

NCT06252675

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of California, Davis Davis, California, United States

University of California, Los Angeles Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

View Trial Details

Hemic and Lymphatic Diseases

Hemic and Lymphatic Diseases trial results

Related conditions